Find A Doctor Find A Service Make An Appointment Talk To A Doctor

banner
increase text size decrease text size printer friendly



  • Lung Cancer

  • Lung Cancer

    Title(s):
    CTSU CALGB 30610. Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide

    Investigator(s):
    Esther Rehmus, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Lung Cancer

    Title(s):
    RTOG 1306. A Randomized Phase II Study of Individualized Combined Modality Therapy for Stage III Non-Small Cell Lung Cancer (NSCLC)

    Investigator(s):
    Mitchel Fromm, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Lung Cancer

    Title(s):
    CTSU A151216. Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)

    Investigator(s):
    Esther Rehmus, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Lung Cancer

    Title(s):
    CTSU A081105. Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)

    Investigator(s):
    Esther Rehmus, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Lung Cancer

    Title(s):
    CTSU E4512. A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein

    Investigator(s):
    Esther Rehmus, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Lung Cancer

    Title(s):
    NRG-BR001. A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases

    Investigator(s):
    Mitchel Fromm, MD

    Contact Information:
    McDowell Cancer Center at 330-344-6348

  • Lung Cancer

    Title(s):
    SWOG 1403. A Randomized Phase II/III Trial of Afatinib Plus Cetuximab Versus Afatinib Alone in Treatment-Naive Patients with Advanced, EGFR Mutation Positive Non-Small Cell Lung Cancer (NSCLC) (BI 1200.124)

    Investigator(s):
    Esther Rehmus, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Lung Cancer

    Title(s):
    NRG-CC003. Randomized Phase II/III Trial of Prophylactic Cranial Irradiation with or without Hippocampal Avoidance for Small Cell Lung Cancer

    Investigator(s):
    Mitchel Fromm, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  •  




    Akron General Medical Center • 1 Akron General Avenue (Formerly 400 Wabash Avenue) • Akron, OH 44307 • 330-344-6000 • 1-800-221-4601    © 2016 Akron General Health System
    Find Us on Facebook button


    This website is certified by Health On the Net Foundation. Click to verify.

      This site complies with the HONcode standard for trustworthy health information: verify here.